MARKET

RUSL

RUSL

Direxion Daily Russia Bull 2X ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

18.97
-0.30
-1.54%
Closed 13:00 11/27 EST
OPEN
18.99
PREV CLOSE
19.27
HIGH
19.10
LOW
18.88
VOLUME
60.23K
TURNOVER
--
52 WEEK HIGH
83.00
52 WEEK LOW
5.66
TOTAL ASSET
46.02M
YTD YIELD
-75.49%
1D
5D
1M
3M
1Y
5Y
News
Performance
Expectations Of The ECB's Monetary Policy Framework Review Are Now Framed By Disinflation And Eurozone Fragmentation Risks
The declining trend in eurozone fragmentation risk is meeting resistance.The ECB signals that it will become the first global central bank to adopt "Sustainable Easing" into its monetary policy framework.ECB defined "Sustainable Easing" conflates Global Warming with emergency COVID-19 pandemic bond-buying permanently.Spain is a growing risk of contagion that could spread fragmentation risk throughout the eurozone.If managed correctly, rising fragmentation risk can be the catalyst for MMT.
Seekingalpha · 10/05 19:56
A Single Trade Just Pulled Half a Billion Dollars From TIPS Fund
Bloomberg · 10/01 16:48
Interesting Timing, But Exciting Russia ETF Is Worth Considering
With a U.S. presidential election just weeks away, the timing of conversations regarding almost anything related to Russia is, well, interesting to put things delicately.
Benzinga · 10/01 14:30
The Secretive Committee Behind the S&P 500 
Bloomberg · 10/01 10:52
Welcome to Bloomberg Wealth: A Letter From the Editor
Today we are launching Bloomberg Wealth to help you manage your finances, live your best life and navigate your path to prosperity. That sentiment may seem to sit at odds with the bleakness of this year, but we believe these volatile times make our mission more necessary.
Bloomberg · 10/01 08:00
The First Blank-Check ETF Makes Its Trading Debut
Bloomberg · 10/01 04:01
Europe Resuming Astra Shot Review; Japan Stimulus: Virus Update
European regulators are set to start an accelerated review of a Covid-19 vaccine front-runner from the University of Oxford and AstraZeneca Plc, even as the U.S. Food and Drug Administration is reported to have widened its investigation into a trial participant who fell ill.
Bloomberg · 10/01 00:33
Stocks Gain on Stimulus Hopes in Choppy Trading: Markets Wrap
Bloomberg · 09/30 21:27
More
No Data
Learn about the latest financial forecast of RUSL. Analyze the recent business situations of Direxion Daily Russia Bull 2X ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
-4.5824%
--
3-Month
-1.9258%
--
6-Month
-58.4742%
--
1-Year
-75.4943%
--
3-Year
-28.0873%
--
5-Year
-9.0284%
--
Since Inception
-38.0099%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
Direxion Daily Russia Bull 2X ETF
Risk
Low risk
Inception Date
2011-05-25
Benchmark
Russell MidCap Value TR
Advisor Company
Direxion Funds
Custodian
The Bank of New York Mellon
Manager
Brigandi/Ng